SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors

A clue to the histogenesis for tumor diagnosis

Rie Ohtomo, Taisuke Mori, Shinsuke Shibata, Koji Tsuta, Akiko M. Maeshima, Chihiro Akazawa, Yukio Watabe, Kazufumi Honda, Tesshi Yamada, Seiichi Yoshimoto, Masao Asai, Hideyuki Okano, Yae Kanai, Hitoshi Tsuda

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Salivary gland tumors are relatively rare and morphologically diverse and heterogeneous tumors; therefore, histogenesis-based tumor markers are sorely needed to aid in diagnosing and determining the cell type of origin. SRY-related HMG-box 10 (SOX10) protein is a transcription factor known to be crucial in the specification of the neural crest and maintenance of Schwann cells and melanocytes. In addition, positive expression has also been implicated in the major salivary gland. Here, we examined SOX10 expression in various salivary gland tumors to correlate this expression with myoepithelial markers. Overall, 76 malignant and 14 benign tumors were examined. SOX10 expression clearly delineated two distinct subtypes of human salivary gland tumors; acinic cell carcinomas, adenoid cystic carcinomas, epithelial-myoepithelial carcinomas, myoepithelial carcinomas, and pleomorphic adenomas, including the pleomorphic adenoma component of carcinoma, were SOX10 positive, while salivary duct carcinomas, mucoepidermoid carcinomas, an oncocytic carcinoma, Oncocytomas, and Warthin tumors were SOX10 negative. Also, SOX10 was expressed in solid-type or non-specific morphology salivary gland tumors, but was not expressed in poorly differentiated squamous cell carcinomas. In normal human salivary gland tissue, SOX10 expression was specific to the nuclei of acini and both luminal and abluminal cells of intercalated ducts but not in other sites. Moreover, the murine model suggested that SOX10 continued to be expressed from the developmental stage to adulthood in the acinar and both luminal and abluminal intercalated ducts in the major salivary gland. Thus, SOX10 is a novel marker for diagnosing and understanding the histogenesis of salivary gland tumors.

Original languageEnglish
Pages (from-to)1041-1050
Number of pages10
JournalModern Pathology
Volume26
Issue number8
DOIs
Publication statusPublished - 2013 Aug

Fingerprint

Glandular and Epithelial Neoplasms
Carcinoma
Salivary Glands
Pleomorphic Adenoma
Neoplasms
Adenolymphoma
Acinar Cell Carcinoma
Salivary Ducts
Mucoepidermoid Carcinoma
Oxyphilic Adenoma
Adenoid Cystic Carcinoma
Neural Crest
Melanocytes
Schwann Cells
Tumor Biomarkers
Squamous Cell Carcinoma
Transcription Factors
Maintenance
Proteins

Keywords

  • p63
  • Salivary gland development
  • Salivary gland tumor
  • SOX10

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors : A clue to the histogenesis for tumor diagnosis. / Ohtomo, Rie; Mori, Taisuke; Shibata, Shinsuke; Tsuta, Koji; Maeshima, Akiko M.; Akazawa, Chihiro; Watabe, Yukio; Honda, Kazufumi; Yamada, Tesshi; Yoshimoto, Seiichi; Asai, Masao; Okano, Hideyuki; Kanai, Yae; Tsuda, Hitoshi.

In: Modern Pathology, Vol. 26, No. 8, 08.2013, p. 1041-1050.

Research output: Contribution to journalArticle

Ohtomo, R, Mori, T, Shibata, S, Tsuta, K, Maeshima, AM, Akazawa, C, Watabe, Y, Honda, K, Yamada, T, Yoshimoto, S, Asai, M, Okano, H, Kanai, Y & Tsuda, H 2013, 'SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: A clue to the histogenesis for tumor diagnosis', Modern Pathology, vol. 26, no. 8, pp. 1041-1050. https://doi.org/10.1038/modpathol.2013.54
Ohtomo, Rie ; Mori, Taisuke ; Shibata, Shinsuke ; Tsuta, Koji ; Maeshima, Akiko M. ; Akazawa, Chihiro ; Watabe, Yukio ; Honda, Kazufumi ; Yamada, Tesshi ; Yoshimoto, Seiichi ; Asai, Masao ; Okano, Hideyuki ; Kanai, Yae ; Tsuda, Hitoshi. / SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors : A clue to the histogenesis for tumor diagnosis. In: Modern Pathology. 2013 ; Vol. 26, No. 8. pp. 1041-1050.
@article{a785c81d4c7b4ad3955d0bcb5a628845,
title = "SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: A clue to the histogenesis for tumor diagnosis",
abstract = "Salivary gland tumors are relatively rare and morphologically diverse and heterogeneous tumors; therefore, histogenesis-based tumor markers are sorely needed to aid in diagnosing and determining the cell type of origin. SRY-related HMG-box 10 (SOX10) protein is a transcription factor known to be crucial in the specification of the neural crest and maintenance of Schwann cells and melanocytes. In addition, positive expression has also been implicated in the major salivary gland. Here, we examined SOX10 expression in various salivary gland tumors to correlate this expression with myoepithelial markers. Overall, 76 malignant and 14 benign tumors were examined. SOX10 expression clearly delineated two distinct subtypes of human salivary gland tumors; acinic cell carcinomas, adenoid cystic carcinomas, epithelial-myoepithelial carcinomas, myoepithelial carcinomas, and pleomorphic adenomas, including the pleomorphic adenoma component of carcinoma, were SOX10 positive, while salivary duct carcinomas, mucoepidermoid carcinomas, an oncocytic carcinoma, Oncocytomas, and Warthin tumors were SOX10 negative. Also, SOX10 was expressed in solid-type or non-specific morphology salivary gland tumors, but was not expressed in poorly differentiated squamous cell carcinomas. In normal human salivary gland tissue, SOX10 expression was specific to the nuclei of acini and both luminal and abluminal cells of intercalated ducts but not in other sites. Moreover, the murine model suggested that SOX10 continued to be expressed from the developmental stage to adulthood in the acinar and both luminal and abluminal intercalated ducts in the major salivary gland. Thus, SOX10 is a novel marker for diagnosing and understanding the histogenesis of salivary gland tumors.",
keywords = "p63, Salivary gland development, Salivary gland tumor, SOX10",
author = "Rie Ohtomo and Taisuke Mori and Shinsuke Shibata and Koji Tsuta and Maeshima, {Akiko M.} and Chihiro Akazawa and Yukio Watabe and Kazufumi Honda and Tesshi Yamada and Seiichi Yoshimoto and Masao Asai and Hideyuki Okano and Yae Kanai and Hitoshi Tsuda",
year = "2013",
month = "8",
doi = "10.1038/modpathol.2013.54",
language = "English",
volume = "26",
pages = "1041--1050",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors

T2 - A clue to the histogenesis for tumor diagnosis

AU - Ohtomo, Rie

AU - Mori, Taisuke

AU - Shibata, Shinsuke

AU - Tsuta, Koji

AU - Maeshima, Akiko M.

AU - Akazawa, Chihiro

AU - Watabe, Yukio

AU - Honda, Kazufumi

AU - Yamada, Tesshi

AU - Yoshimoto, Seiichi

AU - Asai, Masao

AU - Okano, Hideyuki

AU - Kanai, Yae

AU - Tsuda, Hitoshi

PY - 2013/8

Y1 - 2013/8

N2 - Salivary gland tumors are relatively rare and morphologically diverse and heterogeneous tumors; therefore, histogenesis-based tumor markers are sorely needed to aid in diagnosing and determining the cell type of origin. SRY-related HMG-box 10 (SOX10) protein is a transcription factor known to be crucial in the specification of the neural crest and maintenance of Schwann cells and melanocytes. In addition, positive expression has also been implicated in the major salivary gland. Here, we examined SOX10 expression in various salivary gland tumors to correlate this expression with myoepithelial markers. Overall, 76 malignant and 14 benign tumors were examined. SOX10 expression clearly delineated two distinct subtypes of human salivary gland tumors; acinic cell carcinomas, adenoid cystic carcinomas, epithelial-myoepithelial carcinomas, myoepithelial carcinomas, and pleomorphic adenomas, including the pleomorphic adenoma component of carcinoma, were SOX10 positive, while salivary duct carcinomas, mucoepidermoid carcinomas, an oncocytic carcinoma, Oncocytomas, and Warthin tumors were SOX10 negative. Also, SOX10 was expressed in solid-type or non-specific morphology salivary gland tumors, but was not expressed in poorly differentiated squamous cell carcinomas. In normal human salivary gland tissue, SOX10 expression was specific to the nuclei of acini and both luminal and abluminal cells of intercalated ducts but not in other sites. Moreover, the murine model suggested that SOX10 continued to be expressed from the developmental stage to adulthood in the acinar and both luminal and abluminal intercalated ducts in the major salivary gland. Thus, SOX10 is a novel marker for diagnosing and understanding the histogenesis of salivary gland tumors.

AB - Salivary gland tumors are relatively rare and morphologically diverse and heterogeneous tumors; therefore, histogenesis-based tumor markers are sorely needed to aid in diagnosing and determining the cell type of origin. SRY-related HMG-box 10 (SOX10) protein is a transcription factor known to be crucial in the specification of the neural crest and maintenance of Schwann cells and melanocytes. In addition, positive expression has also been implicated in the major salivary gland. Here, we examined SOX10 expression in various salivary gland tumors to correlate this expression with myoepithelial markers. Overall, 76 malignant and 14 benign tumors were examined. SOX10 expression clearly delineated two distinct subtypes of human salivary gland tumors; acinic cell carcinomas, adenoid cystic carcinomas, epithelial-myoepithelial carcinomas, myoepithelial carcinomas, and pleomorphic adenomas, including the pleomorphic adenoma component of carcinoma, were SOX10 positive, while salivary duct carcinomas, mucoepidermoid carcinomas, an oncocytic carcinoma, Oncocytomas, and Warthin tumors were SOX10 negative. Also, SOX10 was expressed in solid-type or non-specific morphology salivary gland tumors, but was not expressed in poorly differentiated squamous cell carcinomas. In normal human salivary gland tissue, SOX10 expression was specific to the nuclei of acini and both luminal and abluminal cells of intercalated ducts but not in other sites. Moreover, the murine model suggested that SOX10 continued to be expressed from the developmental stage to adulthood in the acinar and both luminal and abluminal intercalated ducts in the major salivary gland. Thus, SOX10 is a novel marker for diagnosing and understanding the histogenesis of salivary gland tumors.

KW - p63

KW - Salivary gland development

KW - Salivary gland tumor

KW - SOX10

UR - http://www.scopus.com/inward/record.url?scp=84881312645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881312645&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2013.54

DO - 10.1038/modpathol.2013.54

M3 - Article

VL - 26

SP - 1041

EP - 1050

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 8

ER -